As of September 29, 2026, Indivior Pharmaceuticals's top three insider holders are Joseph Ciaffoni (Chief Executive Officer, 790.33K shares), Ryan Preblick (Chief Financial Officer, 284.75K shares), Christian Heidbreder (Chief Scientific Officer, 209.34K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Joseph Ciaffoni | Chief Executive Officer | 790,330 | 0 | 790,330 | 49.1% | 23 Jun, 2026 |
| 2 | Ryan Preblick | Chief Financial Officer | 284,751 | 0 | 284,751 | 17.7% | 10 Jun, 2026 |
| 3 | Christian Heidbreder | Chief Scientific Officer | 209,337 | 0 | 209,337 | 13.0% | 13 Jul, 2026 |
| 4 | Jeffrey W Burris | Chief Legal Officer | 71,518 | 0 | 71,518 | 4.4% | 05 Mar, 2026 |
| 5 | David E. Wheadon | Director | 45,175 | 0 | 45,175 | 2.8% | 14 May, 2026 |
| 6 | Daniel A Ninivaggi | Director | 44,086 | 0 | 44,086 | 2.7% | 14 May, 2026 |
| 7 | Mark Stejbach | Director | 43,934 | 0 | 43,934 | 2.7% | 14 May, 2026 |
| 8 | Patrick A Barry | Chief Commercial Officer | 31,380 | 0 | 31,380 | 1.9% | 12 Feb, 2026 |
| 9 | Woodrow D Anderson | Chief Accounting Officer | 27,638 | 0 | 27,638 | 1.7% | 27 Aug, 2026 |
| 10 | Keith Humphreys | Director | 21,844 | 0 | 21,844 | 1.4% | 14 May, 2026 |
| 11 | Barbara Ryan | Director | 14,205 | 0 | 14,205 | 0.9% | 14 May, 2026 |
| 12 | Juliet Thompson | Director | 12,973 | 0 | 12,973 | 0.8% | 14 May, 2026 |
| 13 | Stuart A Kingsley | Director | 12,100 | 0 | 12,100 | 0.8% | 14 May, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 27 Aug, 2026 | Woodrow D Anderson | Chief Accounting Officer | Acquired P | 1,500 | $35.69 | $53.54K | 27,638 | Direct |
| 05 Aug, 2026 | Woodrow D Anderson | Chief Accounting Officer | Acquired P | 1,500 | $36.28 | $54.42K | 26,138 | Direct |
| 10 Jul, 2026 | Christian Heidbreder | Chief Scientific Officer | Disposed S | 18,586 | $41.14 | $764.63K | 209,337 | Direct |
| 22 Jun, 2026 | Joseph Ciaffoni | Chief Executive Officer | Acquired M | 1,266,903 | — | — | 1,402,879 | Direct |
| 22 Jun, 2026 | Joseph Ciaffoni | Chief Executive Officer | Disposed F | 612,549 | $38.32 | $23.47Mn | 790,330 | Direct |
| 22 Jun, 2026 | Joseph Ciaffoni | Chief Executive Officer | Disposed M | 1,266,903 | — | — | 0 | Direct |
| 11 Jun, 2026 | Christian Heidbreder | Chief Scientific Officer | Disposed S | 18,586 | $38.06 | $707.38K | 227,923 | Direct |
| 08 Jun, 2026 | Ryan Preblick | Chief Financial Officer | Disposed S | 36,000 | $37.70 | $1.36Mn | 284,751 | Direct |
| 13 May, 2026 | Stuart A Kingsley | Director | Acquired A | 6,518 | $0.00 | $0 | 12,100 | Direct |
| 13 May, 2026 | Keith Humphreys | Director | Acquired A | 6,518 | $0.00 | $0 | 16,042 | Direct |
| 12 May, 2026 | Juliet Thompson | Director | Disposed F | 1,117 | $38.28 | $42.76K | 6,455 | Direct |
| 13 May, 2026 | Mark Stejbach | Director | Acquired A | 6,518 | $0.00 | $0 | 27,087 | Direct |
| 13 May, 2026 | Daniel A Ninivaggi | Director | Acquired A | 6,518 | $0.00 | $0 | 27,163 | Direct |
| 13 May, 2026 | Barbara Ryan | Director | Acquired A | 6,518 | $0.00 | $0 | 12,242 | Direct |
| 13 May, 2026 | David E. Wheadon | Director | Acquired A | 10,430 | $0.00 | $0 | 30,780 | Direct |
| 13 May, 2026 | Juliet Thompson | Director | Acquired A | 6,518 | $0.00 | $0 | 12,973 | Direct |
| 14 Mar, 2026 | Ryan Preblick | Chief Financial Officer | Acquired M | 6,302 | — | — | 323,594 | Direct |
| 14 Mar, 2026 | Ryan Preblick | Chief Financial Officer | Disposed F | 2,843 | $31.11 | $88.45K | 320,751 | Direct |
| 14 Mar, 2026 | Ryan Preblick | Chief Financial Officer | Disposed M | 6,302 | — | — | 0 | Direct |
| 13 Mar, 2026 | Barbara Ryan | Director | Acquired P | 8 | $31.09 | $249 | 5,724 | Direct |